Low expression of lnc-CCDC170–4:1 and ESR1 are associated with lymph node metastasis and FIGO stage, so it may be a potential biomarker to evaluate the prognosis of cervical cancer. The gene discussed is CCDC170; the disease is metastatic malignant neoplasm in the lymph nodes.